Systematic review / meta-analysis / 2015
Twenty blood-borne biomarkers may serve as priority predictors of mortality risk
In a systematic review of 23 cohort studies, 20 out of 51 evaluated blood-borne indicators were associated with mortality risk. Meta-analyses identified associations between mortality and C-reactive protein (all-cause HR 1.42, p<0.001; cancer HR 1.62, p<0.009; CVD HR 1.31, p=0.033), NT-proBNP, and white blood cell count. Several additional markers showed potential utility, whereas others had equivocal support or lacked fatal risk connections.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of prospective cohort studies
- Who was studied
- 23 prospective cohort studies, participants aged 50 to 75 years at baseline
- What was measured
- All-cause, cardiovascular, and cancer mortality
THE PAPER
Blood-borne biomarkers of mortality risk: systematic review of cohort studies.
Barron E, Lara J, White M, Mathers JC. PLoS One, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.